Distinguishing Patients With Distant Metastatic Differentiated Thyroid Cancer Who Biochemically Benefit From Next Radioiodine Treatment

BACKGROUND: Repeated radioiodine ((131)I) treatment (RT) are commonly performed in patients with (131)I-avid distant metastatic differentiated thyroid cancer (DM-DTC), but more precise indications remain indeterminate. This prospective study was conducted to explore predictors for biochemical respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Sa, Ri, Cheng, Lin, Jin, Yuchen, Fu, Hao, Shen, Yan, Chen, Libo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701118/
https://www.ncbi.nlm.nih.gov/pubmed/33304320
http://dx.doi.org/10.3389/fendo.2020.587315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7701118/
https://www.ncbi.nlm.nih.gov/pubmed/33304320
http://dx.doi.org/10.3389/fendo.2020.587315

Ejemplares similares